Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07315516

Sleep and Stress Study

The Effects of Natural Bioactive Compounds on Sleep and Stress: A Randomized Double-Blind Placebo-Controlled Trial

Status
Not Yet Recruiting
Phase
Phase 2
Study type
Interventional
Enrollment
240 (estimated)
Sponsor
RDC Clinical Pty Ltd · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical trial is to learn if natural supplements (lavender oil, PEA, and OEA) work to improve sleep and reduce stress in adults with moderate stress levels and sleep difficulties. It will also learn about the safety of these natural supplements. The main questions it aims to answer are: * Do these supplements improve sleep quality? * Do they reduce perceived stress levels? * Do they reduce anxiety symptoms? * What medical problems do participants have when taking these supplements? Researchers will compare three active treatment groups (lavender oil, PEA, Trpti which contains OEA) to a placebo (a look-alike capsule that contains no active ingredients) to see if these natural supplements work to improve sleep and reduce stress. Participants will take 1 capsule (either active supplement or placebo) every day for 8 weeks and attend 2 clinic visits with a phone check in in between.

Detailed description

The Effects of Natural Bioactive Compounds on Sleep and Stress: A Randomized Double-Blind Placebo-Controlled Trial This four-arm, parallel-group trial evaluates bioactive compounds targeting stress-sleep pathophysiology (lavender oil, PEA, and OEA). The 8-week intervention employs validated psychometric instruments alongside salivary biomarkers providing objective HPA axis and circadian rhythm assessment. The trial enrolls 240 participants (60 per arm) with moderate stress (PSS ≥14) and sleep complaints.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTLavender Oil85mg CPO Lavender oil will be administered daily. This will be taken as a capsule, 1 capsule daily for 57 days.
DIETARY_SUPPLEMENTPalmitoylethanolamide (PEA)75mg Levagen+ PEA will be administered daily. This will be taken as a capsule, 1 capsule daily for 57 days.
DIETARY_SUPPLEMENTOleoylethanolamide150mg Trpti OEA will be administered daily. This will be taken as a capsule, 1 capsule daily for 57 days
OTHERPlaceboA placebo capsule containing microcrystalline cellulose will be taken daily, 1 capsule will be taken each day for 57 days.

Timeline

Start date
2026-02-01
Primary completion
2027-02-01
Completion
2027-02-01
First posted
2026-01-02
Last updated
2026-01-02

Locations

1 site across 1 country: Australia

Source: ClinicalTrials.gov record NCT07315516. Inclusion in this directory is not an endorsement.